Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA.

Bioproperties produces live vaccinations regionally and supplies them to the global food animal sector. There are twelve live vaccines in its current product lineup, and numerous additional registered items are anticipated to come out of its research and development pipeline shortly. Their expertise lies in their capacity to quickly develop new items in response to market demands and bring them to market. The head office in the community manages global distribution and final product warehousing.

Part of Zoetis, Inc., Zoetis Services LLC is a company headquartered in Florham Park, NJ, that discovers, develops, manufactures and sells animal health medicines and vaccines.

Boehringer Ingelheim Vetmedica GmbH, part of C.H. Boehringer Sohn AG & Co. KG, is a German company located in Ingelheim am Rhein that manufactures and sells animal vaccines and pharmaceuticals. Stephan Günther Dolle and Dana Leskova are the current co-CEOs of the firm.

Intervet International BV engages in the manufacture and marketing of animal health products. It offers vaccines, anti-infectives, anti-parasitics, feed additives and products for fertility management. The firm products are used for treatment and care of poultry, pigs, cattle, sheep, goats, horses, fish, shrimp and companion animals. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands.

Amoco Corporation is a global chemical and oil company that provides kerosene and gasoline products. The company is also engaged in the exploration and production business. The company’s products include axle grease for industrial machinery, paraffin wax for candles, and kerosene for home lighting, drive-through filling stations, and gasoline tanker trucks. Amoco Corporation was founded in 1889 by John. D. Rockefeller and is headquartered in Illinois.

Provides research on animal and plant healthcare, material sciences and biotechnology

Takara Shuzo Co. Ltd. manufactures and markets alcoholic beverages. Its products include alcoholic beverages, raw alcohol, health drinks, and seasonings. The company was founded in 1925 and is headquartered in Kyoto, Japan.

Takara Bio Inc., develops, manufactures, and distributes a wide range of life science reagents and kits under the Takara®, Clontech®, and Cellartis® brands. Key products include SMART® cDNA synthesis kits for a variety of samples and applications, including NGS; high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes); Cellartis stem cells and stem cell reagents; RT enzymes and SMART library construction kits; the innovative In-Fusion® cloning system; Guide-it™ gene editing tools; Tet-based inducible gene expression systems; and Living Colors® fluorescent proteins. These and other products support applications including NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi, gene editing, and stem cell studies; and plant and food research

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.

Beijing Enjisai Biotechnology Co., Ltd., established on 2011-11-24, Business scope includes biotechnology development,Biotechnology Services;Sales of chemical products(Does not contain a class of precursor chemicals and dangerous goods),laboratory glassware,cosmetic,Class I medical device.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Merial, Inc. develops pharmaceutical products and vaccines for pets and wildlife. It provides healthcare products and food for dogs, cats, cattle, horse, and poultry producers. The company was founded in August 1997 and is headquartered in Duluth, GA.

Inke Innovation (Suzhou) Biotechnology Co., Ltd., established on 2013-05-24, The scope of business includes research and development of in vitro diagnostic reagents and clinical testing equipment,Production,Sales and related technical consultation and after-sales service;Sales:Class II medical device.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Class III Medical Device Leasing(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Class II Medical Device Leasing;Sales of Class I Medical Devices;Production of Class I Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technical extension services;Specialty Chemicals Sales(Free of Hazardous Chemicals);Technology Import and Export;Import and export;Sales of plastic products;Metal Products Sales;software sales;software development;Glassware Sales;Sales of technical glass products;New material technology research and development;Medical Research and Experimental Development;Wholesale of electronic components;Wholesale of computer software, hardware and auxiliary equipment;Development of Human Gene Diagnosis and Therapy Technology;Teaching equipment sales;Experimental analysis instrument sales;Instrument Repair;pet service(No Animal Treatment)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. Its products include genetic engineering vaccines and multivalent vaccines. The company also provides technical services. Pulike Biological Engineering was founded in 1995 and is headquartered in Luoyang, China.

Sankyo Co., Ltd. engages in the manufacture and sale of pachinko and pachislot machines. It operates through the following segments: Pachinko Machines Business, Pachislot Machines Business, Ball Bearing Supply Systems Business, and Others. The Pachinko Machines Business segment produces and sells pachinko machines, machine gauges and its related parts. The Pachislot Machines Business segment markets pachislot machines and related parts. The Ball Bearing Supply Systems segment sells pachinko and pachislot ball feeders, card system equipment, and parlor-related equipment. The Others segment comprises of mobile content service, real estate, golf club operations, and sells general molding products. The company was established on April 12, 1966 and is headquartered in Tokyo, Japan.

Stratagene California is an American biotechnological company based in La Jolla, California, a maker of life science research and diagnostic products. It was established in 1984 and incorporated in California. It has been involved with the fields of cellular analysis, cloning, cytogenomics, DNA methylation and DNA Sizing and Quantification and food testing. In 2007, Agilent Technologies acquired Stratagene for $250 million, spinning off certain business assets and licensing certain molecular diagnostics technology to a new entity, Decisive Diagnostics. As of October 2011, the Chief Executive of the new company is Joseph Sorge, original founder and CEO of Stratagene.